Alshehri, MM; Sharifi-Rad, J; Herrera-Bravo, J; Jara, EL; Salazar, LA; Kregiel, D; Uprety, Y; Akram, M; Iqbal, M; Martorell, M and Torrens-Mas, M (2021). Therapeutic potential of isoflavones with an emphasis on daidzein. Oxid. Med. Cell. Longev., 9: 6331630-6331637.
Askaripour, M; Najafipour, H; Saberi, S; Jafari, E and Rajabi, S (2022a). Daidzein mitigates oxidative stress and inflammation in the injured kidney of ovariectomized rats: AT1 and Mas receptor functions. Iran. J. Kidney Dis., 1: 32-43.
Askaripour, M; Najafipour, H; Saberi, Sh; Yazdani, S; Jafarinejad-Farsangi, S; Rajabi, S; Jafari, E; Proost, P; Struyf, S and Poosti, F (2022b). Isoflavone daidzein ameliorates renal dysfunction and fibrosis in a postmenopausal rat model: Intermediation of angiotensin AT1 and Mas receptors and microRNAs 33a and 27a. Iran. J. Basic. Med. Sci., 25: 1317-1325.
Bijkerk, R; Au, YW; Stam, W; Duijs, JM; Koudijs, A; Lievers, E; Rabelink, TJ and Van Zonneveld, AJ (2019). Long non-coding RNAs Rian and Miat mediate myofibroblast formation in kidney fibrosis. Front. Pharmacol., 10: 215-223.
Chen, G; Wang, Z; Wang, D; Qiu, C; Liu, M; Chen, X; Zhang, Q; Yan, G and Cui, Q (2012). LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic. Acids. Res., 41: D983-D986.
Desmawati, D and Sulastri, D (2019). Phytoestrogens and their health effect. Open Access Maced. J. Med. Sci., 7: 495-499.
Dixon, A and Maric, C (2007). 17β-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-β protein expression and signaling. J. Physiol. Renal Physiol., 293: F1678-F1690.
Dumanski, SM; Ramesh, S; James, MT; Metcalfe, A; Nerenberg, K; Seely, EW; Robertson, HL and Ahmed, SB (2017). The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis. Syst. Rev., 6: 1-10.
Esteban, V; Lorenzo, O; Rupérez, M; Suzuki, Y; Mezzano, S; Blanco, J; Kretzler, M; Sugaya, T; Egido, J and Ruiz-Ortega, M (2004). Angiotensin II, via AT1 and AT2 receptors and NF-κB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol., 15: 1514-1529.
Fan, H; Lv, Z; Gan, L; Ning, C; Li, Z; Yang, M; Zhang, B; Song, B; Li, G; Tang, D and Gao, J (2019). A novel lncRNA regulates the toll-Like receptor signaling pathway and related immune function by stabilizing FOS mRNA as a competitive endogenous RNA. Front. Immunol., 10: 838-847.
Ferrario, CM (2011). ACE 2: More of Ang 1-7 or less Ang II?. Curr. Opin. Nephrol. Hypertens., 20: 1-5.
Gaete, L; Tchernitchin, AN; Bustamante, R; Villena, J; Lemus, I; Gidekel, M; Cabrera, G and Astorga P (2012). Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth. J. Med. Food. 15: 1081-1090.
Guo, Y; Li, G; Gao, L; Cheng, X; Wang, L; Qin, Y and Zhang, D (2021). Exaggerated renal fibrosis in lncRNA Gas5-deficient mice after unilateral ureteric obstruction. Life. Sci., 264: 118656.
Guttman, M; Russell, P; Ingolia Nicholas, T; Weissman Jonathan, S and Lander Eric, S (2013). Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell. 154: 240-251.
Ignarski, M; Islam, R and Müller, RU (2019). Long non-coding RNAs in kidney disease. Int. J. Mol. Sci., 20: 3276.
Jiang, X; Zhang, F and Ning, Q (2015). Losartan reverses the down-expression of long noncoding RNA-NR024118 and Cdkn1c induced by angiotensin II in adult rat cardiac fibroblasts. Pathol. Biol., 63: 122-125.
Kaeidi, A; Sahamsizadeh, A; Allahtavakoli, M; Fatemi, I; Rahmani, M; Hakimizadeh, E and Hassanshahi, J (2020). The effect of oleuropein on unilateral ureteral obstruction induced-kidney injury in rats: the role of oxidative stress, inflammation and apoptosis. Mol. Biol. Rep., 47: 1371-1379.
Khaksari, M; Abbasloo, E; Dehghan, F; Soltani, Z and Asadikaram, G (2015). The brain cytokine levels are modulated by estrogen following traumatic brain injury: Which estrogen receptor serves as modulator?. Int. Immunopharmacol., 28: 279-287.
Laddha, AP and Kulkarni, YA (2020). Daidzein attenuates kidney damage in diabetic rats. FASEB. J., 34: 1-1.
Li, L; Liu, J; Wang, X; Xiong, X; Huang, S and Wang, X (2021). Microarray analysis of differentially expressed long non-coding RNAs in daidzein-treated lung cancer cells. Oncol. Lett., 22: 789-799.
Li, HB; Zi, PP; Shi, HJ; Gao, M and Sun, RQ (2018). Role of signaling pathway of long non-coding RNA growth arrest-specific transcript 5/microRNA-200c-3p/angiotensin converting enzyme 2 in the apoptosis of human lung epithelial cell A549 in acute respiratory distress syndrome. Chin. Med. J., 98: 3354-3359.
Rajabi, S; Najafipour, H; Jafarinejad-Farsangi, S; Joukar, S; Beik, A; Iranpour, M and Kordestani, Z (2020). Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway. BMC Complement Med. Ther., 20: 1-12.
Rajabi, S; Najafipour, H; Sheikholeslami, M; Jafarinejad-Farsangi, S; Beik, A; Askaripour, M and Miri Karam, Z (2022). Perillyl alcohol and quercetin modulate the expression of non-coding RNAs MIAT, H19, miR-29a, and miR-33a in pulmonary artery hypertension in rats. Non-coding RNA Res., 7: 27-33.
Rostami, B; Nematbakhsh, M; Pezeshki, Z; Talebi, A; Sharifi, MR; Moslemi, F; Eshraghi-Jazi, F and Ashrafi, F (2014). Effect of testosterone on Cisplatin-induced nephrotoxicity in surgically castrated rats. Nephro-Urol. Mon., 6: e21546.
Sawicki, KT; Chang, HC; Shapiro, JS; Bayeva, M; De Jesus, A; Finck, BN; Wertheim, JA; Blackshear, PJ and Ardehali, H (2018). Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21. J. Clin. Investig. Insight. 3: e95948-e95959.
Su, H; Xu, X; Yan, C; Shi, Y; Hu, Y; Dong, L; Ying, S; Ying, K and Zhang, R (2018). LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension. Respir. Res., 19: 1-18.
Sun, J; Zhang, S; Shi, B; Zheng, D and Shi, J (2017). Transcriptome identified lncRNAs associated with renal fibrosis in UUO rat model. Front. Physiol., 8: 658-668.
Teixeira, LB; Parreiras-e-Silva, LT; Bruder-Nascimento, T; Duarte, DA; Simões, SC; Costa, RM; Rodríguez, DY; Ferreira, PA; Silva, CA; Abrao, EP and Oliveira, EB (2017). Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy. Sci. Rep., 7: 11903-11913.
Tomar, A; Kaushik, S; Khan, SI; Bisht, K; Nag, TC; Arya, DS and Bhatia, J (2020). The dietary isoflavone daidzein mitigates oxidative stress, apoptosis, and inflammation in CDDP-induced kidney injury in rats: Impact of the MAPK signaling pathway. J. Biochem. Mol. Toxicol., 34: e22431.
Ucero, AC; Benito-Martin, A; Izquierdo, MC; Sanchez-Nino, MD; Sanz, AB; Ramos, AM; Berzal, S; Ruiz-Ortega, M; Egido, J and Ortiz, A (2014). Unilateral ureteral obstruction: beyond obstruction. Int. Urol. Nephrol., 46: 765-776.
Vellanki, K and Hou, S (2018). Menopause in CKD. Am. J. Kidney Dis., 71: 710-719.
Vitale, DC; Piazza, C; Melilli, B; Drago, F and Salomone, S (2013). Isoflavones: estrogenic activity, biological effect and bioavailability. Eur. J. Drug Metab. Pharmacokinet., 38: 15-25.
Wang, M; Chen, DQ; Chen, L; Cao, G; Zhao, H; Liu, D; Vaziri, ND; Guo, Y and Zhao, YY (2018). Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. Br. J. Pharmacol., 175: 2689-2708.
Wu, N; Zhang, X; Bao, Y; Yu, H; Jia, D and Ma, C (2019). Down-regulation of GAS5 ameliorates myocardial ischaemia/reperfusion injury via the miR-335/ROCK1/AKT/GSK-3β axis. J. Cell. Mol. Med., 23: 8420-8431.
Xiao, X; Yuan, Q; Chen, Y; Huang, Z; Fang, X; Zhang, H; Peng, L and Xiao, P (2019). LncRNA ENST00000453774.1 contributes to oxidative stress defense dependent on autophagy mediation to reduce extracellular matrix and alleviate renal fibrosis. J. Cell. Physiol., 234: 9130-9143.
Xie, H; Xue, JD; Chao, F; Jin, YF and Fu, Q (2016). Long non-coding RNA-H19 antagonism protects against renal fibrosis. Oncotarget., 7: 51473-51481.
Yu, Y; Jiang, H; Niu, Y; Huang, J; Zhang, X; Liu, X; Zhang, Y; Liu, S; Fu, H and Yu, C (2020). Long noncoding RNA-GAS5 retards renal fibrosis through repressing miR-21 activity. Exp. Mol. Pathol., 116: 104518-104529.
Zhang, Y; Zhang, YY; Xia, F; Yang, AX; Qian, JX; Zhao, H and Tao, WY (2019). Effect of lncRNA-MIAT on kidney injury in sepsis rats via regulating miR-29a expression. Eur. Rev. Med. Pharmacol. Sci., 23: 10942-10949.
Zhou, Q; Chung, ACK; Huang, XR; Dong, Y; Yu, X and Lan, HY (2014). Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am. J. Pathol., 184: 409-417.
Zhou, X; Zhang, W; Jin, M; Chen, J; Xu, W and Kong, X (2017). lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy. Cell. Death Dis., 8: e2929-e2937.
Zhu, XH; Yuan, YX; Rao, SL and Wang, P (2016). LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150. Eur. Rev. Med. Pharmacol. Sci., 20: 3653-3660.
)